These services include specialized options tailored to various cancer types. The PSMA PET CT scan is designed for prostate ...

PSMA PET scans enable precise detection of prostate cancer even in its earliest stages, improving diagnostic accuracy and ...

Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval: Melbourne, Australia Saturday, January 18, 2025, 10:00 Hrs [IST] Telix Pharmace ...

In morning trade on Friday, the ASX 200 healthcare stock is up 4.5% to a record high of $27.00. Get the latest from The ...

Telix Pharmaceuticals Limited today announces that it has received a positive decision on the Marketing Authorization ...

PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...

Prostate cancer stands as the third most common cancer among Malaysian men, with 70 percent of cases diagnosed at advanced ...

Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

New imaging technique has shown that many cases of prostate cancer may be more advanced than conventional imaging suggests. Read on!

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.